Alexandria Real Estate Equities
ARE
#2220
Rank
A$12.52 B
Marketcap
A$72.48
Share price
-2.06%
Change (1 day)
-51.39%
Change (1 year)
Alexandria Real Estate Equities, Inc. is a real estate investment trust that invests in office buildings and laboratories.

Earnings for Alexandria Real Estate Equities (ARE)

Earnings in 2025 (TTM): -A$19.73 Million

According to Alexandria Real Estate Equities 's latest financial reports the company's current earnings are A$2.97 Billion. In 2024 the company made an earning of A$1.05 Billion, an increase over its 2023 earnings that were of A$0.53 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Alexandria Real Estate Equities from 2013 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$19.73 Million-101.87%
2024 A$1.05 B96.11%
2023 A$0.53 B-53.56%
2022 A$1.15 B-3.96%
2021 A$1.20 B-20.26%
2020 A$1.51 B72.88%
2019 A$0.87 B3.11%
2018 A$0.84 B73.54%
2017 A$0.48 B464.88%
2016 A$86.41 M-77.32%
2015 A$0.38 B36.31%
2014 A$0.27 B-10.81%
2013 A$0.31 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
A$17.91 B-57,124.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A$14.94 B-47,665.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$34.02 B-108,373.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
A$1.50 B-4,887.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$12.14 B-38,749.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$12.46 B-39,765.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
A$0.19 B-727.01%๐Ÿ‡บ๐Ÿ‡ธ USA